Feedback / Questions
FR104 - OSE Immunotherapeutics
FR104: Initiation of P2 trial for rheumatoid arthritis in 2019
(OSE Immunotherapeutics)
-
Jun 19, 2019 -
Corporate Overview
New P2 trial
https://ose-immuno.com/wp-content/uploads/2019/05/OSE_Corporate_May-2019-3.pdf
Jun 19, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious